Propoxyphene
Darvocet, Darvon, Dolene, Kesso-gesic, Prophene, Wygesic (propoxyphene) is a small molecule pharmaceutical. Propoxyphene was first approved as Darvocet on 1982-01-01. It is used to treat pain in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Aspirin
+
Propoxyphene hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DARVON W/ ASA | Xanodyne Pharmaceuticals | N-010996 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Aspirin
+
Caffeine
+
Propoxyphene hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DARVON COMPOUND | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
| DARVON COMPOUND-65 | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
Hide discontinued
Propoxyphene hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DARVON | Xanodyne Pharmaceuticals | N-010997 DISCN | 1982-01-01 | 2 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| darvon-n | New Drug Application | 2009-10-27 |
| propoxyphene | ANDA | 2009-10-27 |
| propoxyphene and acetaminophen | ANDA | 2010-08-03 |
| propoxyphene hydrochloride and acetaminophen | 2007-02-16 | |
| propoxyphene napsylate and acetaminophen | ANDA | 2011-06-20 |
| propoxyphene napsylate and acetominophen | 2008-11-18 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | — | — | — | 1 | — | 1 |
| Cancer pain | D000072716 | — | G89.3 | — | — | — | 1 | — | 1 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | 1 | — | 1 |
| Pathologic constriction | D003251 | — | — | — | — | — | 1 | — | 1 |
| Spinal stenosis | D013130 | EFO_0007490 | M48.0 | — | — | — | 1 | — | 1 |
| Healthy volunteers/patients | — | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Recurrence | D012008 | — | — | — | 1 | 1 | — | — | 1 |
| Tissue adhesions | D000267 | — | — | — | 1 | 1 | — | — | 1 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Propoxyphene |
| INN | dextropropoxyphene |
| Description | Levopropoxyphene is a 1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate. It has a role as an antitussive. It is an enantiomer of a dextropropoxyphene. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C |
Identifiers
| PDB | — |
| CAS-ID | 469-62-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1213351 |
| ChEBI ID | 51173 |
| PubChem CID | 200742 |
| DrugBank | DB00647 |
| UNII ID | S2F83W92TK (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Propoxyphene
+
Acetaminophen
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Propoxyphene
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2,021 documents
View more details
Safety
Black-box Warning
Black-box warning for: Darvon-n, Propoxyphene, Propoxyphene and acetaminophen
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
12,991 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use